Evaluation of Myocardial Changes in Familial Amyloid Polyneuropathy after Liver Transplantation

被引:25
作者
Okamoto, Sadahisa [1 ]
Yamashita, Taro [1 ]
Ando, Yukio [2 ]
Ueda, Mitsuharu [2 ]
Misumi, Yohei [1 ]
Obayashi, Konen [2 ]
Horibata, Yoko [2 ]
Uchino, Makoto [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Honjo, Japan
[2] Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Med, Honjo, Japan
关键词
familial amyloid polyneuropathy; echocardiogram; cardiac amyloidosis; liver transplantation;
D O I
10.2169/internalmedicine.47.1399
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The progression of cardiac amyloidosis is a prognostic factor after liver transplantation (LT) in familial amyloid polyneuropathy (FAP). The aim of this study was to assess myocardial changes in FAP amyloidgenic transthyretin (ATTR) Val30Met after LT. Patients and Methods Twelve Japanese FAP ATTR Val30Met patients who underwent LT and were followed for more than 2 years, were examined with serial echocardiography after LT. Serum BNP levels were measured in 9 patients. Results A significant increase in mean left atrial diameter and interventricular septal thickness was observed after LT. The increase in left atrial diameter was correlated with the presence of granular sparkling echo (GSE) at preoperative examination. Serum brain natriuretic peptide (BNP) levels in patients with left atrial diameter dilation (152.0 +/- 157.6 pg/mL) were higher than in those without left atrial diameter dilation (32.0 +/- 30.0 pg/mL). Conclusion LAD and IVS were significantly increased after LT compared with preoperative examinations in Japanese FAP ATTR Val30Met patients. BNP is an important biochemical indicator of myocardiac dysfunction in FAP patients. GSE is a useful echocardiographic marker to predict cardiac amyloidosis after LT.
引用
收藏
页码:2133 / 2137
页数:5
相关论文
共 18 条
[1]   EFFECT OF LIVER-TRANSPLANTATION ON AUTONOMIC DYSFUNCTION IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY TYPE-I [J].
ANDO, Y ;
TANAKA, Y ;
ANDO, E ;
YAMASHITA, T ;
NISHIDA, Y ;
TASHIMA, K ;
SUGA, M ;
UCHINO, M ;
ANDO, M .
LANCET, 1995, 345 (8943) :195-196
[2]   B-type natriuretic peptide in cardiovascular disease [J].
de Lemos, JA ;
McGuire, DK ;
Drazner, MH .
LANCET, 2003, 362 (9380) :316-322
[3]   Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy [J].
Delahaye, Nicolas ;
Rouzet, Francois ;
Sarda, Laure ;
Tamas, Carmen ;
Dinanian, Sylvie ;
Plante-Bordeneuve, Violaine ;
Adams, David ;
Samuel, Didier ;
Merlet, Pascal ;
Syrota, Andre ;
Slama, Michel S. ;
Le Guludec, Dominique .
MEDICINE, 2006, 85 (04) :229-238
[4]   A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure [J].
Doust, JA ;
Glasziou, PP ;
Pietrzak, E ;
Dobson, AJ .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (18) :1978-1984
[5]   Progression of ventricular wall thickening after liver transplantation for familial amyloidosis [J].
Dubrey, SW ;
Davidoff, R ;
Skinner, M ;
Bergethon, P ;
Lewis, D ;
Falk, RH .
TRANSPLANTATION, 1997, 64 (01) :74-80
[6]   RAPID VENTRICULAR INDUCTION OF BRAIN NATRIURETIC PEPTIDE GENE-EXPRESSION IN EXPERIMENTAL ACUTE MYOCARDIAL-INFARCTION [J].
HAMA, N ;
ITOH, H ;
SHIRAKAMI, G ;
NAKAGAWA, O ;
SUGA, S ;
OGAWA, Y ;
MASUDA, I ;
NAKANISHI, K ;
YOSHIMASA, T ;
HASHIMOTO, Y ;
YAMAGUCHI, M ;
HORI, R ;
YASUE, H ;
NAKAO, K .
CIRCULATION, 1995, 92 (06) :1558-1564
[7]   Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis [J].
Koyama, J ;
Ray-Sequin, PA ;
Falk, RH .
CIRCULATION, 2002, 106 (05) :556-561
[8]   Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction [J].
Krishnaswamy, P ;
Lubien, E ;
Clopton, P ;
Koon, J ;
Kazanegra, R ;
Wanner, E ;
Gardetto, N ;
Garcia, A ;
DeMaria, A ;
Maisel, AS .
AMERICAN JOURNAL OF MEDICINE, 2001, 111 (04) :274-279
[9]   Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type [J].
Olofsson, BO ;
Backman, C ;
Karp, K ;
Suhr, OB .
TRANSPLANTATION, 2002, 73 (05) :745-751
[10]   Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis [J].
Palladini, G ;
Campana, C ;
Klersy, C ;
Balduini, A ;
Vadacca, G ;
Perfetti, V ;
Perlini, S ;
Obici, L ;
Ascari, E ;
d'Eril, GM ;
Moratti, R ;
Merlini, G .
CIRCULATION, 2003, 107 (19) :2440-2445